Literature DB >> 15815969

Complementary medicine in chronic cancer care.

Daniel A Monti1, Jingduan Yang.   

Abstract

Although advancements in cancer care have led to increased cure rates and survival times, those coping with the long-term sequelae of a cancer diagnosis often report high levels of distress, poor health-related quality of life, and unmet psychosocial needs. The shortcomings of the conventional biomedical system at sufficiently addressing these chronic illness issues are a primary reason that many patients turn to complementary and alternative medicine (CAM). Although patients usually use such treatments in addition to conventional care, they often do not discuss doing so with their conventional physicians, who are perceived as being unreceptive to the topic. Physicians may feel uninformed about CAM treatments, especially given the relatively small amount of data on the topic available in the medical literature. This article reviews a few CAM modalities commonly used by cancer survivors and those with chronic cancer illness, with a particular focus on familiarizing physicians with treatments that may potentially complement regular oncologic care by decreasing stress and enhancing health-related quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 15815969     DOI: 10.1053/j.seminoncol.2004.11.026

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  8 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  Stress and intervention preferences of patients with brain tumors.

Authors:  Stephen T Keir; Ann Bebe Guill; Karen E Carter; Henry S Friedman
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

3.  Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Authors:  Colin P White; Gerilynn Hirsch; Sunil Patel; Fatin Adams; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  Cancer survivors with unmet needs were more likely to use complementary and alternative medicine.

Authors:  Jun J Mao; Steve C Palmer; Joseph B Straton; Peter F Cronholm; Shimrit Keddem; Kathryn Knott; Marjorie A Bowman; Frances K Barg
Journal:  J Cancer Surviv       Date:  2008-04-15       Impact factor: 4.442

Review 5.  Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort.

Authors:  Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

6.  Origanum majorana Attenuates Nephrotoxicity of Cisplatin Anticancer Drug through Ameliorating Oxidative Stress.

Authors:  Amel M Soliman; Shreen Desouky; Mohamed Marzouk; Amany A Sayed
Journal:  Nutrients       Date:  2016-05-05       Impact factor: 5.717

7.  Cancer-related stress and complementary and alternative medicine: a review.

Authors:  Kavita D Chandwani; Julie L Ryan; Luke J Peppone; Michelle M Janelsins; Lisa K Sprod; Katie Devine; Lara Trevino; Jennifer Gewandter; Gary R Morrow; Karen M Mustian
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-15       Impact factor: 2.629

8.  Adaptogenic potential of a polyherbal natural health product: report on a longitudinal clinical trial.

Authors:  Dugald Seely; Rana Singh
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.